Becton, Dickinson and Company To Present At The Deutsche Bank 39th Annual Health Care Conference

Published: May 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FRANKLIN LAKES, N.J., May 2, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014, at 10:00 a.m. (EDT).

A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, May 14, 2014.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.

Contact:
Monique N. Dolecki, Investor Relations 201-847-5378
Alyssa J. Zeff, Corporate Communications 201-847-4358

SOURCE BD (Becton, Dickinson and Company)



Help employers find you! Check out all the jobs and post your resume.

Back to news